![]() |
市場調査レポート
商品コード
1800974
蒸気オートクレーブの市場レポート:構成別、技術別、用途別、地域別、2025~2033年Steam Autoclaves Market Report by Configuration, Technology, Application, and Region 2025-2033 |
||||||
カスタマイズ可能
|
蒸気オートクレーブの市場レポート:構成別、技術別、用途別、地域別、2025~2033年 |
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2~3営業日
|
世界の蒸気オートクレーブの市場規模は2024年に29億米ドルに達しました。今後、IMARC Groupは、2033年には54億米ドルに達し、2025~2033年の成長率(CAGR)は6.91%になると予測しています。感染管理の重要性の高まり、医薬品やライフサイエンス分野の研究開発活動の拡大、外来ヘルスケアの台頭、小型卓上オートクレーブへの需要などが市場成長を後押しする主な要因です。
感染制御と患者の安全性重視の高まり
業界の主要な促進要因の1つは、ヘルスケア環境における感染制御と患者の安全性への注目が高まっていることです。HAIは患者の安全性に重大な脅威をもたらし、罹患率、死亡率、ヘルスケアコストの増加につながる可能性があります。例えば、米国食品医薬品局が発表した論文によると、医療機器によって引き起こされる医療関連感染(HCAI)は、患者の健康と生命を危険にさらすだけでなく、患者とヘルスケアシステムにさらなる経済的負担を強います。感染症は、再使用可能な医療機器の洗浄・消毒・滅菌の不備、植え込み後の機器への細菌付着、外部通信機器による皮膚破裂など、さまざまな要因の結果として発生する可能性があります。蒸気オートクレーブは、医療器具、機器、消耗品の滅菌に重要な役割を果たし、病原体の感染を防ぎ、HAIのリスクを低減することで、蒸気オートクレーブの市場シェアに貢献しています。ヘルスケアプロバイダーが感染リスクの低減と患者ケアの質の向上に努める中、信頼性が高く効率的な滅菌ソリューションへの需要が高まっています。例えば、米国食品医薬品局(FDA)が2023年1月に発表した記事によると、FDAの医療機器・放射線衛生センター(CDRH)の無菌性・感染管理プログラムによって規制科学研究が実施され、微生物学的および生化学的汚染のない安全で機能的な医療機器を患者が利用できるようにすることが支援されています。これらの要因は、蒸気オートクレーブ市場予測にプラスの影響を与えています。
研究開発活動の拡大
製薬、バイオテクノロジー、ライフサイエンス産業は、研究開発(R&D)活動の活発化によって力強い成長を遂げています。これらの業界は、実験の完全性を維持し、製品の安全性と有効性を確保するために、実験機器や材料の無菌性に大きく依存しています。例えば、LTE Scientificは2024年3月、実験用オートクレーブの最新ライン、Touchclave-Vシリーズを発売しました。Touchclave-Vシリーズは、ほとんどの実験室用途に対応できる低価格のソリューションを提供します。Touchclave-Vシリーズは、容量50リットルと80リットルのトップローディング式円筒チャンバーオートクレーブで、シンプルに設計されています。これは、蒸気オートクレーブ市場の最近の価格にさらにプラスの影響を与えています。また、研究開発(R&D)への投資の増加が、これらの品目を確実かつ効率的に滅菌できるオートクレーブへの需要を後押ししています。科学の進歩や革新的な発見がこれらの分野のさらなる成長を促進するため、この動向は続くと思われます。例えば、2024年5月、多発性硬化症、ループス、関節リウマチなどの自己免疫疾患に対する精密治療法を生み出すために、ダークゲノムの非コードDNA領域の解読を専門とするバイオテクノロジー企業、Nucleome Therapeuticsは、研究を支援するためにLTE研究グレードのオートクレーブを購入しました。これらの要因が蒸気オートクレーブ市場の収益をさらに押し上げています。
技術の進歩
蒸気オートクレーブの技術的進歩により、滅菌プロセスの効率が向上しています。強化されたサイクル制御、自動化機能、最適化された加熱・冷却機構は、サイクル時間の短縮とスループットの向上に貢献し、ヘルスケア施設は器具や機器をより迅速かつ効果的に滅菌することができます。例えば、2024年3月、Syntegonの子会社であるSchoeller-Bleckmann Medizintechnik(SBM)は、滅菌器の新シリーズであるSBM Essential Lineを発売しました。SBM Essential Lineの滅菌器は、真空-蒸気(ADV)、蒸気-空気混合(SDR)、または複合(SDT)のいずれかの手順を使用して、多孔質および固体の機器、ならびにバイアル、カートリッジ、ペンなどの容器内の液体を消毒します。滅菌後の迅速な冷却のために、ファン、ジャケット冷却、内部熱交換器が提供されています。また、メーカーは、滅菌効果を損なうことなく、サイクルタイムを短縮した蒸気オートクレーブを開発するために、絶えず技術革新を行っています。高度な加熱・冷却機構、最適化されたサイクルアルゴリズム、急速排気システムにより、高性能オートクレーブは器具をより迅速に滅菌し、ヘルスケア施設におけるワークフローの効率とスループットを向上させます。例えば、2024年5月、技術、業務コンサルティング、プロジェクト管理サービスの世界的プロバイダーであるCAIは、高性能滅菌システムの製造・サービスプロバイダーであるFedegari Groupと協業しました。この契約は、ライフサイエンスおよびバイオテクノロジー業界の企業の蒸気滅菌能力を向上させるものです。このパートナーシップの目的は、蒸気滅菌科学の応用を向上させるとともに、滅菌工程の設置時間を短縮し、生涯コストの削減、製品コストの削減、製造工程の合理化を図ることです。これらの要因が蒸気オートクレーブの市場シェアに貢献しています。
The global steam autoclaves market size reached USD 2.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6.91% during 2025-2033. The growing emphasis on infection control, expanding R&D activities in pharmaceuticals and life sciences, the rise of ambulatory healthcare, and demand for compact tabletop autoclaves, are some of the major factors propelling the market growth.
Surging Emphasis on Infection Control and Patient Safety
One of the primary drivers of the industry is the increasing focus on infection control and patient safety within healthcare settings. HAIs pose a significant threat to patient safety and can lead to increased morbidity, mortality, and healthcare costs. For instance, according to an article published by the U.S. Food and Drug Administration, healthcare-associated infections (HCAIs) caused by medical devices not only risk patients' health and lives but also place an additional financial burden on patients and the healthcare system. Infections can arise as a result of a variety of factors, including poor cleaning, disinfection, and sterilization of reusable medical devices, bacterial adhesion to devices after implantation, and skin breaches caused by external communication devices. Steam autoclaves play a critical role in sterilizing medical instruments, equipment, and supplies to prevent the transmission of pathogens and reduce the risk of HAIs, thereby contributing to the steam autoclaves market share. In confluence with this, as healthcare providers strive to reduce the risk of infections and improve the quality of patient care, there is a growing demand for reliable and efficient sterilization solutions. For instance, according to an article published by the U.S. Food and Drug Administration in January 2023, regulatory science research is carried out by the FDA's Sterility and Infection Control Program at the Center for Devices and Radiological Health (CDRH) to help guarantee that patients have access to safe and functional medical devices that are devoid of microbiological and biochemical contamination. These factors are positively influencing the steam autoclaves market forecast.
Expanding Research and Development Activities
The pharmaceutical, biotechnology, and life sciences industries are experiencing robust growth, driven by the increasing research and development (R&D) efforts. These industries heavily rely on the sterility of laboratory equipment and materials to maintain the integrity of experiments and ensure the safety and efficacy of products. For instance, in March 2024, LTE Scientific launched its newest line, the Touchclave-V series of laboratory autoclaves. The Touchclave-V series provides a low-cost solution that can handle the majority of laboratory applications. The Touchclave-V series is a top-loading cylindrical chambered autoclave with capacities of 50 and 80 liters, designed for simplicity. This is further positively impacting the steam autoclaves market's recent price. Apart from this, growing investments in research and development (R&D) are propelling the demand for autoclaves that can reliably and efficiently sterilize these items. This trend is likely to persist as scientific advancements and innovative discoveries drive further growth in these sectors. For instance, in May 2024, Nucleome Therapeutics, a biotech company that specializes in decoding the dark genome's non-coding DNA regions to produce precision treatments for autoimmune disorders such as multiple sclerosis, lupus, and rheumatoid arthritis, purchased an LTE research-grade autoclave to aid in research. These factors are further bolstering the steam autoclaves market revenue.
Technological Advancements
Technological advancements in steam autoclaves have led to increased efficiency in sterilization processes. Enhanced cycle controls, automation features, and optimized heating and cooling mechanisms contribute to shorter cycle times and higher throughput, allowing healthcare facilities to sterilize instruments and equipment more quickly and effectively. For instance, in March 2024, Schoeller-Bleckmann Medizintechnik (SBM), a Syntegon subsidiary, launched the SBM Essential Line, a new range of sterilizers. The SBM Essential Line's sterilizers disinfect porous and solid equipment, as well as liquids in containers such as vials, cartridges, or pens, using either a vacuum-steam (ADV), steam-air mixture (SDR), or combined (SDT) procedure. Fans, jacket cooling, and internal heat exchangers are offered for quick cooling following sterilization. Apart from this, manufacturers are continually innovating to develop steam autoclaves with shorter cycle times without compromising sterilization efficacy. Advanced heating and cooling mechanisms, optimized cycle algorithms, and rapid exhaust systems enable high-performance autoclaves to sterilize instruments more quickly, improving workflow efficiency and throughput in healthcare facilities. For instance, in May 2024, CAI, a global provider of technical, operational consulting, and project management services, collaborated with Fedegari Group, a producer and service provider of high-performance sterilization systems. This agreement will improve steam sterilization capabilities for firms in the life sciences and biotech industries. The partnership's purpose is to improve the application of steam sterilization science while reducing sterilization process installation time in order to reduce lifetime costs, slash product costs, and streamline manufacturing processes. These factors are contributing to the steam autoclaves market share.
Table top steam autoclaves dominate the market
According to the steam autoclaves outlook, the increasing prevalence of smaller healthcare facilities, including dental clinics, veterinary practices, and smaller outpatient centers, is fueling the demand for compact and space-efficient sterilization solutions such as tabletop steam autoclaves. Tabletop autoclaves are ideal for such settings as they are compact, easy to install, and do not occupy valuable floor space. In addition to this, the rise of mobile healthcare units and field-based medical services, especially in remote or underserved areas, necessitates portable sterilization equipment. Tabletop autoclaves offer the mobility and flexibility required to ensure sterile conditions in these dynamic environments. Furthermore, their user-friendly interfaces and automated features make them accessible to a range of healthcare professionals, including those without extensive technical expertise. This accessibility factor further contributes to the growing demand for tabletop steam autoclaves across diverse healthcare and field-service applications.
Gravity displacement holds the largest share in the market
According to the steam autoclaves market overview, gravity displacement autoclaves are particularly well-suited for sterilizing delicate instruments, porous materials, and liquids that might be adversely affected by the vigorous air removal processes of pre-vacuum autoclaves. This gentler approach to air removal minimizes the risk of damaging sensitive items while still ensuring effective sterilization. In line with this, gravity displacement autoclaves are often more cost-effective than their pre-vacuum counterparts, making them a preferred choice for facilities with budget constraints, thereby aiding in market expansion. Moreover, their simplicity and ease of operation also appeal to a variety of industries, including dental clinics, small laboratories, and educational institutions, where specialized technical expertise may be limited. The demand for gravity displacement autoclaves continues to grow among users who prioritize efficient, yet gentle sterilization methods without compromising on effectiveness or affordability.
Medical represents the leading application segment
The demand for steam autoclaves in medical applications is primarily driven by the critical need for sterility and infection control within healthcare settings. In the medical field, maintaining aseptic conditions is paramount to prevent infections, safeguard patient well-being, and ensure successful surgical procedures. Steam autoclaves play a pivotal role in achieving these objectives by providing reliable and efficient sterilization of surgical instruments, medical devices, and equipment. With the global population aging and the healthcare industry continuously evolving, there is a growing number of medical facilities, including hospitals, clinics, and ambulatory surgery centers, all of which require sterilization solutions. Additionally, the increasing prevalence of outpatient care and the demand for rapid sterilization turnaround times, especially in emergency departments, drive the adoption of autoclaves tailored to the specific needs of these medical settings. Consequently, the demand for steam autoclaves in medical applications remains robust as healthcare providers prioritize patient safety and infection prevention. For instance, in December 2022, the Government of Mauritius, with the help of the Government of Japan, and the United Nations Development Program (UNDP) launched a new 500L autoclave at Victoria Hospital to commemorate the Ministry of Health and Wellness's cooperation with UNDP.
North America exhibits a clear dominance, accounting for the largest steam autoclaves market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
According to the steam autoclaves market overview, North America's well-established healthcare infrastructure and the constant need for infection control measures in hospitals and medical facilities fuel the demand for sterilization equipment, including steam autoclaves. Besides this, the stringent regulatory standards and guidelines set by organizations such as the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) further emphasize the importance of maintaining sterile conditions, encouraging healthcare providers to invest in advanced autoclave technologies. Moreover, the rise in the prevalence of chronic illness and a rapidly aging population in North America result in higher demand for surgical procedures and medical interventions, boosting the need for reliable autoclaves in healthcare settings. In addition to this, the region's robust pharmaceutical and biotechnology industries, including vaccine production and research activities, drive the requirement for autoclaves for the sterilization of laboratory equipment and materials, thereby bolstering the market growth. Furthermore, the ongoing emphasis on research and development (R&D), coupled with technological advancements in steam autoclave design and functionality, is supporting the market growth. For instance, in February 2024, Dothan City Commissioners approved the group Daniels Sharpsmart to install autoclave in order to sterilize medical gauze, bandages, gowns, sharps, etc.
The market is characterized by intense competition among key players and a diverse range of manufacturers. Prominent companies dominate the market, leveraging their extensive product portfolios, established brand recognition, and global distribution networks. These industry leaders continuously invest in research and development to introduce innovative features like advanced sterilization cycles, user-friendly interfaces, and energy-efficient technologies, maintaining their competitive edge. Additionally, strategic mergers, acquisitions, and collaborations are common in the market, allowing companies to expand their product offerings and market reach. Price competitiveness and customization options have become vital for survival in this competitive landscape as customers seek cost-effective solutions tailored to their specific needs, creating a dynamic and evolving global steam autoclaves market.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: